XENETIC BIOSCIENCES INC (XBIO) Stock Balance Sheet
NASDAQ:XBIO - Nasdaq - US9840156023 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.17M | 8.98M | 13.10M | 18.24M | 11.53M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 422.00K | 603.80K | 560.00K | 480.00K | 850.00K | |||
| Total Current Assets | 6.59M | 9.59M | 13.65M | 18.72M | 12.37M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 313.90K | 1.02M | 1.07M | 1.09M | 780.00K | |||
| Total Non-Current Assets | 313.90K | 1.02M | 1.07M | 1.10M | 810.00K | |||
| TOTAL ASSETS | 6.90M | 10.61M | 14.72M | 19.82M | 13.18M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 610.70K | 568.80K | 790.00K | 1.06M | 610.00K | |||
| Accounts Payable | 283.60K | 240.80K | 290.00K | 360.00K | 330.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 894.30K | 809.60K | 1.07M | 1.42M | 940.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 20.00K | |||
| TOTAL LIABILITIES | 894.30K | 809.60K | 1.07M | 1.42M | 960.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -197.19M | -193.23M | -189.10M | -182.55M | -176.90M | |||
| Additional Paid In Capital | 208.23M | 208.05M | 207.76M | 205.95M | 194.13M | |||
| Common Shares | 3.40K | 3.30K | 20.00K | 10.00K | 10.00K | |||
| Treasury Stock | -5.28M | -5.28M | -5.28M | -5.28M | -5.28M | |||
| Other Shareholders' Equity | 253.70K | 253.70K | 250.00K | 250.00K | 250.00K | |||
| Shares Outstanding | 1.54M | 1.54M | 1.52M | 1.34M | 870.00K | |||
| Tangible Book Value per Share | 3.89 | 6.36 | 8.97 | 13.72 | 14.03 | |||
| Total Shareholders' Equity | 6.01M | 9.80M | 13.65M | 18.39M | 12.22M | |||
| TOTAL LIABILITIES AND EQUITY | 6.90M | 10.61M | 14.72M | 19.82M | 13.18M | |||
| Statistics | ||||||||
| Current Ratio | 7.37 | 11.84 | 12.76 | 13.18 | 13.16 | |||
| Return On Assets (ROA) | -57.38% | -38.99% | -44.50% | -28.51% | -82.63% | |||
| Return On Equity (ROE) | -65.93% | -42.21% | -47.99% | -30.72% | -89.12% | |||
All data in USD , ROIC based on taxRate of 0.21